Wegovy 1mg Not Feeling Effective? Here's the Clinical Reality

You're three steps in, but you haven't arrived yet

Picture the scene: it's Sunday morning, you pull the pen from the fridge door, inject on schedule, and then wait. Weeks pass. The number on the scales barely moves. It's easy to conclude the medicine isn't working, but the framing matters here.

Wegovy's licensed dosing schedule in the UK runs 0.25mg, 0.5mg, 1mg, 1.7mg, and finally 2.4mg, with roughly four weeks at each level. The 1mg dose is the midpoint, you're not yet where the medicine is designed to be used long-term. The pivotal STEP 1 trial, which reported around 15% average body-weight reduction, measured outcomes at 2.4mg after 68 weeks, not at 1mg mid-escalation. Expecting the full effect at this stage is a bit like judging how a journey feels from the middle of the motorway rather than the destination.

Weight loss on GLP-1 medicines also tends to be non-linear. Many people notice a strong initial response at 0.25mg or 0.5mg, then a quieter patch as the body adapts before responding again at higher doses. A flat spell at 1mg is, for a lot of patients, simply that adaptation window. The full Wegovy dose schedule explains how titration works in practice and what to expect at each step.

The short version: if you've been on 1mg for less than four weeks, or you've only recently stepped up from 0.5mg, the evidence you need hasn't had time to accumulate yet. Give the dose its full window.

Absorption and technique, the variables that are easy to overlook

When a dose feels ineffective, it's worth a quick audit of the mechanics before concluding the medicine has stopped working.

Wegovy is administered subcutaneously, into the fatty layer just under the skin, not into muscle. Consistently injecting into muscle rather than fat can alter absorption. The licensed sites are the abdomen (avoiding the two-inch ring around the navel), the front of the thigh, and the upper arm. Rotating between them, and not reusing the exact same spot week after week, matters more than most people realise.

Pen storage is another quiet culprit. Wegovy must be kept refrigerated at 2–8°C until use; if it's been left out for longer than the window specified in your Patient Information Leaflet (say, left in a car on a warm day, or kept at room temperature beyond the permitted period) potency may be affected. The Mounjaro SmPC on the eMC gives detailed stability data for tirzepatide; Wegovy's own leaflet covers semaglutide's limits. When in doubt, check the leaflet or ask your prescriber.

It's also worth being honest about the lifestyle piece. The clinical trials were run alongside a reduced-calorie diet and increased physical activity. Those context conditions don't disappear once you're on the medicine. Appetite suppression at 1mg is typically milder than at maintenance dose, the food-noise reduction that patients describe at 2.4mg hasn't fully kicked in yet, which makes it harder to run the consistent calorie deficit that drives scale movement. That gap closes as dose increases.

If you're uncertain whether your technique is right, our FAQs cover some common questions, and our aftercare team is available seven days a week.

When does 1mg not working become a genuine clinical concern?

There's an important distinction between a mid-titration plateau (normal, expected) and true non-response (less common, clinically significant).

NICE guidance on semaglutide for weight management (published as TA875) recommends considering whether to continue treatment if someone achieves less than 5% weight reduction after six months at the maintenance dose of 2.4mg. That's six months at 2.4mg, not six months from the very first injection. The 1mg step is part of getting there, not the endpoint against which the medicine is judged.

Genuine reduced response can sometimes have an underlying cause: thyroid conditions, certain medicines (including some antidepressants and corticosteroids), insulin resistance, or periods of significant stress that alter cortisol and appetite regulation. These aren't reasons to stop treatment, they're reasons to have a proper clinical conversation. A prescriber can look at your full picture in a way that a forum thread or a dose-comparison article simply can't.

If you're weighing up whether to continue, or wondering whether a different treatment might suit you better, the weight-loss treatment overview sets out the landscape. And if you've already reached 1.7mg and are still questioning whether the medicine is working, the considerations at that stage are a bit different and worth reading separately.

One more thing worth saying plainly: if you started Wegovy recently and the 0.25mg or 0.5mg phases also felt quiet, that's not unusual, early doses feeling uneventful is a common experience and doesn't predict what happens at maintenance. The 0.25mg phase specifically is designed to be a tolerability starter, not a therapeutic one.

What to do now if 1mg feels ineffective

Talk to your prescriber before making any changes. Don't skip a dose, double up, or decide to stay on 1mg indefinitely without clinical input. The titration schedule exists for good reasons: moving too fast increases gastrointestinal side effects; staying at a sub-therapeutic dose longer than needed delays results without a clear benefit.

Your prescriber can review whether you're due to move to 1.7mg, whether anything in your medical picture might be affecting response, and whether the technique and storage checklist needs a look. If you're concerned about the cost of continuing treatment as doses change, it's worth understanding what to look for in a regulated Wegovy supplier so you're comparing like for like.

The NHS guidance on semaglutide (Wegovy), published on the NHS website, gives a clear patient-level overview of what's normal during treatment, including the gastrointestinal side effects that often accompany dose changes. Worth reading if you haven't already.

At nume, every repeat order goes through a clinical re-review by a GPhC-registered prescriber, a real person reads your update, not a system. If something needs adjusting, that conversation happens before anything is dispensed. Speak to our prescribers if you're on treatment with us and want to discuss where you are in the titration process.